IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,500 | -4.2% | 221,400 | -52.7% | 0.01% | +7.7% |
Q2 2023 | $8,874 | +16.3% | 467,800 | -4.9% | 0.01% | +30.0% |
Q1 2023 | $7,633 | +25.0% | 492,112 | +43.0% | 0.01% | +25.0% |
Q4 2022 | $6,108 | -99.7% | 344,100 | -2.4% | 0.01% | +166.7% |
Q3 2022 | $1,967,000 | +51.7% | 352,500 | +6.0% | 0.00% | +50.0% |
Q2 2022 | $1,297,000 | +133.7% | 332,600 | +230.3% | 0.00% | +100.0% |
Q1 2022 | $555,000 | +270.0% | 100,700 | +472.2% | 0.00% | – |
Q4 2021 | $150,000 | -42.1% | 17,600 | +214.3% | 0.00% | – |
Q4 2020 | $259,000 | -70.7% | 5,600 | -84.6% | 0.00% | -100.0% |
Q2 2020 | $884,000 | – | 36,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,717,182 | $139,213,000 | 3.92% |
Ghost Tree Capital, LLC | 525,000 | $12,784,000 | 3.37% |
Logos Global Management LP | 625,000 | $15,219,000 | 3.04% |
ACUTA CAPITAL PARTNERS, LLC | 350,000 | $8,523,000 | 2.46% |
BVF INC/IL | 1,088,479 | $26,504,000 | 1.63% |
Vivo Capital, LLC | 800,000 | $19,480,000 | 1.40% |
Camber Capital Management LP | 800,000 | $19,480,000 | 1.12% |
Sio Capital Management, LLC | 152,450 | $3,712,000 | 1.08% |
Prosight Management, LP | 95,500 | $2,325,000 | 1.00% |
Parkman Healthcare Partners LLC | 125,125 | $3,047,000 | 0.86% |